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Abstract 
Sister Mary Joseph nodule is an eponym 
assigned to a nurse, first reported in 1949, 
denoting a rare form of cutaneous umbilical 
metastasis. The primary neoplasm is 
usually adenocarcinoma and the 
gastrointestinal tract is the most common 
primary site. The present case 
report describes a 79 year old woman with 
squamous cell cervical carcinoma. Her 
disease was managed with radiation and 
concurrent chemotherapy and no evidence 
of loco-regional recurrent disease was 
noted on follow-up examination.  Eight 
months after treatment, gynecological 
examination suggested recurrent disease. 
Three weeks later, the patient presented 
with a painless umbilical nodule and the 
biopsy revealed a poorly differentiated 
carcinoma. Computed tomography showed 
ascites, diffuse peritoneal carcinomatosis 
including an umbilical nodule, multiple 
pulmonary nodules, bilateral pleural 
effusion, and retroperitoneal 
lymphadenopathy. She died 63 days after 
this manifestation. Review of the literature 
shows that a Sister Mary Joseph nodule is 
a sign of advanced neoplastic disease and 
is associated with poor prognosis. The 
treatment remains palliative either by 
radiation, chemotherapy or surgery.  




The term “Sister Mary 
Joseph nodule” (SMJN) has been 
used since 1949 to denote 
umbilical metastases. Sister Mary 
Joseph was a nurse and the first 
observer to establish a correlation 
between umbilical nodules and 
carcinoma. SMJN is a rare but 
typical cutaneous periumbilical 
metastasis of internal malignancies, 
and its recognition is important 
because it may be the first 
presenting sign of unknown 
malignant disease in a patient.1 
The exact mechanism underlying 
metastases to the umbilicus remains 
unknown. Proposed routes for the 
spread of cancer to the umbilicus 
include direct extension from the 
peritoneum and spread via arteries, 
veins, or lymphatic channels.2 
SMJN is most commonly found in 
association with adenocarcinomas, 
and the most common primary site 
is the gastrointestinal tract (35–
65%). This metastasis impairs the 
quality of life and shortens survival.3  
Although squamous cervical cancer 
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is a common occurrence, the 
association of this condition with 
skin metastasis is rare.  
A search of MEDLINE using search 
terms “umbilical metastasis* AND 
squamous cell cervix cancer” 
yielded 6 cases reported in the 
literature, none of them associated 
with peritoneal carcinomatosis. 
Case Report  
A 79-year-old Caucasian woman 
presented with postmenopausal 
intermittent vaginal bleeding and a 
vegetative mass external to the 
cervix. Gynecological examination 
revealed left parametrium infiltration. 
Ultrasonography showed the 
presence of a 30-mm thickened 
endometrium, and cervical and 
endometrial biopsy revealed a 
poorly differentiated tumor.  
Immunohistochemistry showed that 
the cells were positive for p63 and 
Pan-Keratin and negative for 
cytokeratin 5/6 and S100. These 
features indicated the epithelial 
origin of the neoplastic cells and, as 
there were no criteria for squamous 
cell endometrial carcinoma, the 
patient was classified as having 
stage IIB cervical cancer, and the 
disease was managed with 
concurrent cisplatin-based 
chemoradiation. The pelvis was 
treated with 10 MV photons, 45 Gy 
in 25 daily fractions followed by 
brachytherapy. Follow-up 
examinations included Papanicolaou 
smear and pelvic examination for 6 
months, which revealed no evidence 
of loco-regional residual disease.  
 
Figure 1: Umbilical nodule 
Eight months after 
chemoradiotherapy, gynecological 
examination revealed a pelvic mass 
and left parametrium infiltration, 
suggesting recurrent disease. 
Ultrasonography and magnetic 
resonance imaging were requested. 
Two weeks after this examination, 
the patient was evaluated for 
complaints of abdominal pain and a 
painless umbilical nodule (Figure 1). 
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On examination, a 3-cm exophytic 
necrotic lesion with mucoid and 
bloody discharge, ascites, and an 
abdominal mass growth were noted. 
A biopsy was performed and 
revealed a poorly differentiated 
carcinoma with extensive ulcerated 
necrotic areas infiltrating 
fibroadipose tissue.  
As magnetic resonance was not 
available, computed tomography 
was performed and showed ascites, 
diffuse peritoneal carcinomatosis 
including an umbilical implant, 
multiple pulmonary nodules, bilateral 
pleural effusion, and retroperitoneal 
lymphadenopathy (Figures 2 and 3). 
 
Figure 2: Computed tomography showing umbilical nodule 
Paracentesis was performed, and 
hematic liquid had the following 
properties: mononuclear cells, 4.2 
g/dL total protein, a serum ascites-
albumin gradient of <1.1 g/dL, and 
negative culture. 
The treatment was palliative with 
local excision. 
The patient developed respiratory 
distress and intestinal sub occlusion. 




SMJN is an umbilical tumor usually 
associated with advanced cancer. 
An umbilical mass can present as a 
benign lesion, but also as a primary 
or metastatic malignant tumor.1 
Differential diagnoses include 
umbilical hernia, cutaneous 
endometriosis, pyogenic granuloma, 
melanocytic nevus, keloid, 
melanoma, squamous cell 
carcinoma, and basal cell 
carcinoma.3  
Umbilical nodules are due to a 
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primary tumor and, despite being 
rare, they represent 38% of cases. 
Endometriosis is responsible for 
32%, and metastases, 30%.4 
SMJN is most commonly found in 
association with adenocarcinomas, 
and the most common primary site 
is the gastrointestinal tract (35–
65%). The gynecological tract is 
responsible for 12–35% of cases, 
and in these cases, the ovary is the 
most common primary site.3  
SMJN may have different 
morphological characteristics, such 
as inflammatory erythematous 
thickening of the overlying skin, 
vascular appearance, fissures or 
ulceration, or features mimicking 
incarcerated umbilical hernia.3 In the 
present case, the nodule had a 
necrotic surface with bloody and 
mucoid discharge. 
 
Figure 3: Computed tomography showing secondary peritoneal 
implantation in the right lower abdomen 
Fagundes et al., in a retrospective 
analysis of 1211 patients with 
invasive cervical carcinoma, 
observed that clinical stage, 
endometrial extension prior to 
therapy, histology, and pelvic tumor 
control within each stage were 
indicators of distant dissemination. 
The frequency of metastases was 
greater when endometrial tumor 
extension was detected. 5 Although 
endometrial extension is not 
included in the International 
Federation of Gynecology and 
Obstetrics staging, this extension is 
associated with a high risk of lymph 
node metastases and decreased 
disease-free and overall survival.6  
The superficial squamous tumor 
replaces the entire endometrium in 
the intrauterine spread of cervical 
carcinoma. The tumor must satisfy 
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three criteria (established by 
Fluhmann and modified by Kay) to 
be classified as primary endometrial 
carcinoma: 1) no coexistent 
endometrial adenocarcinoma, 2) no 
continuity between tumor and 
cervical squamous epithelium, and 
3) no primary cervical carcinoma.7 
Cervical carcinoma recurrence is 
most commonly loco-regional.8 
Typical manifestations of recurrence 
involve the pelvis (preserved cervix, 
vagina or vaginal cuff, parametrium, 
bladder, rectum, ureters and 
ovaries) and lymph nodes.9 
However, with the increasing use of 
pelvic irradiation, less typical 
patterns of recurrence such as 
peritoneal carcinomatosis can 
occur.10 These patterns are being 
recognized with greater frequency in 
patients with suspected recurrence 
because of the advancements in 
imaging studies.  
Metastases from cervical carcinoma 
are usually predictable. Distant 
metastasis occurs commonly in the 
lung, liver, and bone.11 Umbilical 
metastasis is extremely rare, and 
the histological type most frequently 
found is adenocarcinoma.12  
Our patient recurred with ascites, 
diffuse peritoneal carcinomatosis, 
umbilical nodule, bilateral pleural 
effusion, multiple pulmonary 
nodules, and retroperitoneal 
lymphadenopathy. 
Skin metastasis is a late 
manifestation in cervical 
cancer patients and is an indication 
of uncontrolled or widespread 
metastasis. Most skin metastases 
occur after an interval of less than 
21 months. The mean survival of 
patients with umbilical metastasis is 
3 months.8  
We presume that the progressive 
involvement of the peritoneum due 
to squamous cell carcinoma might 
have led to spread to the umbilicus, 
and this was likely responsible for 
the unusual course of this case. 
At the time of umbilical metastasis 
diagnosis, the cancer was deemed 
incurable and the umbilical 
metastasis was an indication of 
recurrence. SMJN treatment 
remains palliative either by radiation, 
chemotherapy, surgery alone or in 
combinations.8 
Conclusion 
Sister Mary Joseph nodule is a sign 
of uncontrolled disease. Although 
similar cases have been reported in 
the literature, this manifestation of 
the squamous cell cervical cancer is 
rare and this clinical course 
associated with endometrial 
extension and peritoneal 
carcinomatosis is unique. 
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